(Q42517986)

1 November 2017

title

Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes (English)

1 reference

1 November 2017

11

1 reference

1 November 2017

Lars C Hanker

1

1 reference

1 November 2017

Achim Rody

2

1 reference

1 November 2017

Uwe Holtrich

3

1 reference

1 November 2017

Lajos Pusztai

4

1 reference

1 November 2017

Eugen Ruckhaeberle

5

1 reference

1 November 2017

Cornelia Liedtke

6

1 reference

1 November 2017

Andre Ahr

7

1 reference

1 November 2017

Tomas M Heinrich

8

1 reference

1 November 2017

Nicole Sänger

9

1 reference

1 November 2017

Sven Becker

10

1 reference

1 November 2017

language of work or name

English

0 references

publication date

16 December 2012

1 reference

Breast Cancer Research and Treatment

1 November 2017

published in

1 reference

1 November 2017

volume

137

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

407-416

1 reference

Sequence analysis of mutations and translocations across breast cancer subtypes

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Prognostic and therapeutic implications of distinct kinase expression patterns in different subtypes of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Triple-negative breast cancer: disease entity or title of convenience?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Triple-Negative Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

affy--analysis of Affymetrix GeneChip data at the probe level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Bioconductor: open software development for computational biology and bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

The molecular portraits of breast tumors are conserved across microarray platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Data-driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Breast cancer stem cells, cytokine networks, and the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Targeting breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Cancer immunotherapy comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Cancer immunology--analysis of host and tumor factors for personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Practical implications of gene-expression-based assays for breast oncologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Gene expression profiling in breast cancer: classification, prognostication, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

A clinically relevant gene signature in triple negative and basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Use of archived specimens in evaluation of prognostic and predictive biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Gene-expression signatures in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Breast cancer molecular profiling with single sample predictors: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Challenges translating breast cancer gene signatures into the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

Immune parameters affecting the efficacy of chemotherapeutic regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin C as a Compatible Prognostic Marker in Human Solid Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2356-2

10.1007/S10549-012-2356-2

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

1037596889

0 references

1 reference